05/06/2024 6:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024 6:05 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024 11:15 PM | RedHill Biopharma (Filer)
| Form EFFECT | |
04/18/2024 6:00 AM | RedHill Biopharma (Filer)
| Form POS AM | |
04/08/2024 8:25 AM | RedHill Biopharma (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
04/08/2024 8:28 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024 3:05 PM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
04/03/2024 6:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024 6:02 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024 3:38 PM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024 6:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/05/2024 6:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024 6:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/16/2024 7:54 AM | RedHill Biopharma (Filer)
| Form 424B3 | |
02/15/2024 11:15 PM | RedHill Biopharma (Filer)
| Form EFFECT | |
02/09/2024 3:20 PM | RedHill Biopharma (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
02/05/2024 7:00 AM | RedHill Biopharma (Filer)
| Form D Notice of Exempt Offering of Securities | |
02/01/2024 9:22 AM | CVI Investments, Inc. (Filed by) RedHill Biopharma (Subject)
| Form SC 13G | |
01/26/2024 11:50 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/26/2024 8:29 AM | RedHill Biopharma (Filer)
| Form 424B5 | |
01/26/2024 8:31 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/25/2024 8:09 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/25/2024 5:02 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024 9:23 AM | Empery Asset Management, LP (Filed by) RedHill Biopharma (Subject)
| Form SC 13G/A | |
01/02/2024 3:26 PM | RedHill Biopharma (Subject) SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
12/20/2023 7:45 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023 6:03 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2023 6:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2023 6:03 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/01/2023 3:10 PM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/27/2023 6:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/16/2023 11:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/26/2023 11:15 PM | RedHill Biopharma (Filer)
| Form EFFECT | |
10/26/2023 3:52 PM | RedHill Biopharma (Filer)
| Form 424B3 | |
10/23/2023 3:06 PM | RedHill Biopharma (Filer)
| Form F-3/A | |
10/16/2023 3:05 PM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/13/2023 7:13 AM | RedHill Biopharma (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
10/12/2023 3:05 PM | RedHill Biopharma (Filer)
| Form D Notice of Exempt Offering of Securities | |
10/10/2023 8:08 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2023 6:03 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/29/2023 7:02 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Guard Against the Coming Financial Upheaval (Ad) America’s Most Shocking Financial Story…
Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late. You can stream it for free right here. |
09/22/2023 3:17 PM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2023 6:03 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2023 6:03 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/17/2023 6:07 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/13/2023 11:15 PM | RedHill Biopharma (Filer)
| Form EFFECT | |
08/11/2023 3:52 PM | RedHill Biopharma (Filer)
| Form 424B3 | |
08/09/2023 8:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/08/2023 8:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2023 6:04 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2023 6:03 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2023 12:31 PM | RedHill Biopharma (Filer)
| Form 424B3 | |
07/25/2023 12:33 PM | RedHill Biopharma (Filer)
| Form 424B3 | |
07/25/2023 11:09 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2023 7:00 AM | RedHill Biopharma (Filer)
| Form 424B5 | |
07/21/2023 8:37 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/21/2023 6:02 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/06/2023 6:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/29/2023 6:00 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/29/2023 6:10 AM | RedHill Biopharma (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/12/2023 7:01 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2023 6:02 AM | RedHill Biopharma (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |